TCI GENE Inc. (TPEX:6879)
Taiwan
· Delayed Price · Currency is TWD 33.25
-0.05 (-0.15%)
Mar 10, 2026, 1:34 PM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 881.07 million as of March 9, 2026. Its market cap has decreased by -39.23% in one year.
Market Cap
881.07M
Enterprise Value
30.20M
Revenue
324.73M
Ranking
n/a
PE Ratio
24.66
Stock Price
33.25
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 881.07M, a decrease of -58.73%. That is a compound annual growth rate of -19.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 881.07M | -6.20% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eusol Biotech | 869.95M |
| Neith | 899.73M |
| NatureWise Biotech & Medicals | 916.55M |
| Taiwan Advance Bio-Pharmaceutical | 945.00M |
| BioLASCO Taiwan | 751.71M |
| SynCore Biotechnology Co.,Ltd | 745.50M |
| Holy Stone Healthcare | 1.05B |
| Level Biotechnology | 1.08B |